80710-25-4 Usage
General Description
1-Phenylpiperidin-3-ol, also known as MPPP, is a chemical compound with a phenylpiperidine structure. It is a psychoactive substance that acts as a potent opioid agonist and has been used as a recreational drug due to its euphoric and sedative effects. MPPP is structurally similar to the opioid analgesic pethidine and is believed to produce similar effects. However, MPPP is not approved for medical use and is considered a controlled substance in many countries due to its high potential for abuse and addiction. The recreational use of MPPP is associated with serious health risks, including overdose and dependence, and its production and distribution are illegal.
Check Digit Verification of cas no
The CAS Registry Mumber 80710-25-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,0,7,1 and 0 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 80710-25:
(7*8)+(6*0)+(5*7)+(4*1)+(3*0)+(2*2)+(1*5)=104
104 % 10 = 4
So 80710-25-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H15NO/c13-11-7-4-8-12(9-11)10-5-2-1-3-6-10/h1-3,5-6,11,13H,4,7-9H2
80710-25-4Relevant articles and documents
Ruthenium catalyzed amination cyclization of 1,2,4-butanetriol with primary amines: A borrowing hydrogen strategy for 3-pyrrolidinol synthesis
Xu, Qing-Song,Li, Chen,Xu, Yong,Xu, Defeng,Shen, Mei-Hua,Xu, Hua-Dong
supporting information, (2019/06/04)
A ruthenium based catalytic system ([Ru(p-cymene)Cl2]2/XantPhos with substoichiometric Cs2CO3) has been established to effectively achieve the first direct amination cyclization of 1,2,4-butanetriol with primary
REDUCTION OF 1-SUBSTITUTED 3-OXIDOPYRIDINIUMS
Ashcroft, William R.,Joule, John A.
, p. 1883 - 1887 (2007/10/02)
1-Substituted 3-oxidopyridiniums are smoothly reduced by sodium borohydride in ethanol to give 1-substituted 3-hydroxypiperidines but much less efficiently by lithium aluminum hydride in hot tetrahydrofuran to give mainly, 1-substituted 5-hydroxypiperid-3-eines.
